# FDA Inspection 886636 - Astellas Pharma Inc. - June 25, 2014

Source: https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/8dd9e7ea-0320-4761-8e1a-772453b5b4d2
Source feed: FDA_Inspections

> FDA Inspection 886636 for Astellas Pharma Inc. on June 25, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 886636
- Company Name: Astellas Pharma Inc.
- Inspection Date: 2014-06-25
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1240584 - 2024-04-18](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/2e3de0e1-9d1f-475a-85f3-e04a7c7755fb)
- [FDA Inspection 1095974 - 2019-05-31](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/e871b725-33ca-4a2e-b543-a8afd7d76a52)
- [FDA Inspection 995338 - 2016-11-11](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/afba335b-459c-4410-8d03-ca5cc42652ae)
- [FDA Inspection 770005 - 2012-02-10](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/2d4f2d93-b728-4d30-96ab-d1d8e3af4365)
- [FDA Inspection 548515 - 2008-10-31](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/e0982a5e-2e2c-4c69-8243-69a3864e812a)

Company: https://www.keypedia.com/companies/astellas-pharma-inc/9a5bc049-426d-4313-b8b8-1ce28d48fa42

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c